During this segment, Peter Salgo, MD; Ira M. Klein, MD, MBA, FACP; Michael Kolodziej, MD; Bryan Loy, MD; and Irwin W. Tischler, DO, explain why it has been difficult to establish a core set of quality measures in cancer care. The panelists also discuss the importance of adopting a patient-centered approach to care within healthcare practices.
Despite efforts by various organizations, including the American Society of Clinical Oncology, to develop quality measures to help evaluate and improve quality of care, Drs Kolodziej and Loy note that a lack of harmonization across measures from different organizations creates a challenge. Dr Kolodziej comments that a few areas have been recognized as important by multiple organizations, including emergency department utilization, hospitalization rates, and end-of-life care; however, there is little harmony in terms of other quality measures. Drs Kolodziej and Salgo add that it is necessary to report not only on what is important, but also on what is practical.
Dr Klein explains that the patient-centered approach to care is an extremely important topic to explore during discussions about quality, especially as oncology treatments become more individualized and tailored to each patient.
Dr Tischler remarks that once a patient-centered approach has been established, physicians can alter their practice to better serve the needs of their patients, which can result in better-quality care. Dr Klein notes that the patient-centered approach and the oncology medical home approach can help in achieving the best possible outcomes.
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
A new study highlights significant disparity in reimbursement rates across states between hospitals and Medicare; the first patient to receive a genetically modified pig kidney has died; research examines outcomes of over 500 patients receiving medication abortion pills by mail.
Read More
Oncology Onward: A Conversation With Penn Medicine's Dr Justin Bekelman
December 19th 2023Justin Bekelman, MD, director of the Penn Center for Cancer Care Innovation, sat with our hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, for our final episode of 2023 to discuss the importance of collaboration between academic medicine and community oncology and testing innovative cancer care delivery in these settings.
Listen
Looking Back on ISPOR 2024: Hot Policy Topics, Welcome Focus on Employers, and More
May 10th 2024Kimberly Westrich, MA, chief strategy officer of the National Pharmaceutical Council, reflects on the most valuable learnings from the 2024 meeting of ISPOR—The Professional Society for Health Economics and Outcomes Research, including lively discussions of the Inflation Reduction Act and workshops on value assessment.
Read More